Our research aimed to discover a safe yet effective natural compound capable of inhibiting the binding of PD-1 to PD-L1, specifically in the acidic conditions typical of the tumor microenvironment (pH of 5.5), without affecting PD-L1 at the normal physiological pH. Here, CD274 is linked to neoplasm.